SCHEMBL6133353

SCHEMBL6133353

CCOC(=O)c1nc(-c2ccccc2F)c(-c2ccc(=O)n(C(C)C)n2)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.47
HPGD P15428 6/20 0.47
NPSR1 Q6W5P4 5/20 0.47
HSD17B10 Q99714 3/20 0.47
PTGS2 P35354 1/20 0.39
JAK2 O60674 1/20 0.38
JAK3 P52333 1/20 0.38
KDM4E B2RXH2 7/20 0.37
MEN1 O00255 7/20 0.37
KMT2A Q03164 7/20 0.37
MAPT P10636 5/20 0.37
LMNA P02545 4/20 0.37
ALOX12 P18054 2/20 0.37
CCR6 P51684 1/20 0.37
HKDC1 Q2TB90 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
POLB P06746 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GLA P06280 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133924 0.87 PTGS2 (0.44) ALDH1A1HPGDHSD17B10PTGS2KDM4E
SCHEMBL6133755 0.85 CDC7 (0.37) ALDH1A1HPGDNPSR1HSD17B10JAK2
SCHEMBL6133158 0.85 PTGS2 (0.56) ALDH1A1HPGDNPSR1HSD17B10PTGS2
SCHEMBL6134156 0.85 TSHR (0.42) ALDH1A1HPGDNPSR1HSD17B10KDM4E
SCHEMBL6133357 0.84 TRPM8 (0.45) ALDH1A1HPGDNPSR1HSD17B10PTGS2
SCHEMBL6133413 0.80 PDE4A (0.46) ALDH1A1PTGS2JAK2JAK3KDM4E
SCHEMBL6133504 0.80 LCK (0.38) ALDH1A1HSD17B10KDM4EMEN1KMT2A
SCHEMBL6133426 0.79 TGFBR1 (0.45) ALDH1A1PTGS2KDM4EMAPT
SCHEMBL6133825 0.79 ADORA2A (0.46) ALDH1A1NPSR1HSD17B10KDM4EMEN1
SCHEMBL6134322 0.73 PTGS2 (0.46) ALDH1A1HPGDHSD17B10PTGS2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed
EP-1441732-A2 THIAZOLE DERIVATIVE AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-04 EP disclosed
WO-2003039451-A2 THIAZOLE PYRIDAZINONES AS ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR ALDH1A1 630/4885HPGD 1177/4885NPSR1 432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.